Core Viewpoint - Fengbei Bio's stock price has experienced a significant decline of 25.28% this year, with a notable drop of 2.02% on November 12, 2023, leading to a market capitalization of 7.158 billion yuan [1][2]. Group 1: Stock Performance - As of November 12, 2023, Fengbei Bio's stock price was reported at 49.88 yuan per share, with a trading volume of 48.5745 million yuan and a turnover rate of 3.10% [1]. - The company has seen a net outflow of main funds amounting to 1.8158 million yuan, with large orders buying 5.5954 million yuan and selling 5.0300 million yuan [1]. - The stock has appeared on the "Dragon and Tiger List" once this year, with the latest appearance on November 5, 2023, showing a net purchase of 17.8625 million yuan [1]. Group 2: Financial Performance - For the period from January to September 2025, Fengbei Bio reported a revenue of 2.251 billion yuan, reflecting a year-on-year growth of 62.32%, and a net profit attributable to shareholders of 117 million yuan, which is a 35.32% increase year-on-year [2]. - The company's main business revenue composition indicates that 91.18% comes from waste resource utilization, with bio-based materials contributing 79.60% [1][2]. Group 3: Company Overview - Fengbei Bio, established on July 25, 2014, is located in Jintan District, Changzhou, Jiangsu Province, and primarily focuses on the comprehensive utilization of waste oil resources [1]. - The company operates in the basic chemical industry, specifically in the category of other chemical products, and is classified under several concept sectors including new stocks and biomass energy [2].
丰倍生物跌2.02%，成交额4857.45万元，主力资金净流出181.58万元